TrianglePUBLICATIONS · 19826111
Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Nov 10
- First author
- Quintás-Cardama A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Quintás-Cardama A
- type
- Author
- name
- Kantarjian H
- type
- Author
- name
- Manshouri T
- type
- Author
- name
- Luthra R
- type
- Author
- name
- Estrov Z
- type
- Author
- name
- Pierce S
- type
- Author
- name
- Richie MA
- type
- Author
- name
- Borthakur G
- type
- Author
- name
- Konopleva M
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Verstovsek S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Quintás-Cardama A
- type
- Author
- name
- Kantarjian H
- type
- Author
- name
- Manshouri T
- type
- Author
- name
- Luthra R
- type
- Author
- name
- Estrov Z
- type
- Author
- name
- Pierce S
- type
- Author
- name
- Richie MA
- type
- Author
- name
- Borthakur G
- type
- Author
- name
- Konopleva M
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Verstovsek S
- type
- Author
- bibliography ids
- nci-bib-0ac6767e34b1d17545851a8e
- book metadata
- content sha256
- c21b6d438b7e188392b68cba8107bae33417c31dbee23280d6d435e155ddcd97
- document type
- citation
- dois
- 10.1200/JCO.2009.23.6075
- electronic publication date
- display
- 2009 Oct 13
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19826111
- immutable id
- pubmed:19826111@c21b6d438b7e188392b68cba8107bae33417c31dbee23280d6d435e155ddcd97
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 32
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 5418-24
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19826111
- provenance
- batch id
- 0706b5111d1451f52f74
- provider
- NCBI PubMed ESummary
- record sha256
- 0907c8f306878720cc109639dc724253ca2d9d4b4a1f4082db82f041100e667d
- response sha256
- 98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
- retrieved at
- 2026-09-09T23:46:29.215195+00:00
- publication date
- display
- 2009 Nov 10
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase II
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera.
Preserved source evidence · Not medical advice